Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700811 | European Journal of Surgical Oncology (EJSO) | 2017 | 9 Pages |
Abstract
RH appears to have a positive effect in reducing overall complications, individual adverse events including wound infection, fever, urinary tract infection, transfusion, LOS, EBL, and time to diet than OH for cervical cancer patients. Compared to LH, the current evidence is not enough to clearly determine its clinical safety and effectiveness. Further rigorous prospective studies with long-term follow-up that overcome the many limitations of the current evidence are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
D.A. Park, J.E. Yun, S.W. Kim, S.H. Lee,